Cybin (HELP) Liabilities and Shareholders Equity (2021 - 2026)

Cybin's (HELP) quarterly Liabilities and Shareholders Equity came in at $251.2 million in Q1 2026, up 39.35% YoY from $180.2 million in Q1 2025, and down 13.42% on a QoQ basis from $290.1 million in Q4 2025.

Cybin (HELP) Liabilities and Shareholders Equity (2021 - 2026) Analysis & Trends

Cybin (HELP) has 6 years of Liabilities and Shareholders Equity data on file, last reported at $251.2 million in Q1 2026.

  • Quarterly Liabilities and Shareholders Equity rose 39.35% year-over-year to $251.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $933.3 million (up 22.45% YoY) and the FY2026 annual result came in at $251.2 million, up 39.62% from the prior year.
  • Liabilities and Shareholders Equity fell to $251.2 million in Q1 2026, from $290.1 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $290.1 million in Q4 2025 to a low of $33.8 million in Q1 2023.
  • A 5-year average of $149.8 million and a median of $181.2 million in 2025 frame the typical range for Liabilities and Shareholders Equity.
  • Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity plunged 40.77% — and 2024, when it soared 347.47%.
  • Tracing HELP's Liabilities and Shareholders Equity over 5 years: stood at $44.7 million in 2022, then surged by 113.11% to $95.3 million in 2023, then soared by 90.48% to $181.5 million in 2024, then soared by 59.84% to $290.1 million in 2025, then decreased by 13.42% to $251.2 million in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $251.2 million (Q1 2026), $290.1 million (Q4 2025), and $181.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 27.42 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 41.73 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 10.03 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 4.32 Bn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 9.18 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 15.59 Mn
7 Royalty Pharma 33.72 Bn 35.84 Bn - 19.82 Bn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 5.56 Bn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 2.10 Bn
10 Cybin 417.29 Mn 417.29 Mn - 251.17 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 251.17 Mn
Dec 31, 2025 290.11 Mn
Sep 30, 2025 181.25 Mn
Jun 30, 2025 210.81 Mn
Mar 31, 2025 180.24 Mn
Dec 31, 2024 181.50 Mn
Sep 30, 2024 192.35 Mn
Jun 30, 2024 208.12 Mn
Mar 31, 2024 224.14 Mn
Dec 31, 2023 95.29 Mn
Sep 30, 2023 42.99 Mn
Jun 30, 2023 57.54 Mn
Feb 28, 2023 33.80 Mn
Dec 31, 2022 44.71 Mn
Sep 30, 2022 52.99 Mn
Dec 31, 2021 75.49 Mn
Sep 30, 2021 83.78 Mn
Jun 30, 2021 67.39 Mn
Mar 31, 2021 72.78 Mn